ASX: ALA Arovella Therapeutics Limited ACN 090 987 250 Corporate One, 84 Hotham Street, Preston, VIC 3072 Australia Telephone: + 61 3 9863 6472 [email protected] | www.arovella.com ASX Release 12 August 2026 INVESTOR WEBINAR Arovella Therapeutics...
Investor Webinar Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
In the deck
Earlier from Arovella Therapeutics
- Investor Webinar Registration
- Quarterly Activities/Appendix 4C Cash Flow Report
- Arovella Appoints Acting CEO
- Board Refresh and CEO Resignation
- CLDN18.2 CAR iNKT Cell Preclinical Data Update
Later from Arovella Therapeutics
- Notification regarding unquoted securities - ALA
- Appendix 4E and Annual Report
- Appendix 4G
- Corporate Governance Statement
- Clinical manufacturing batch released, first site activated
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics